Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopPRE trial
2018-000811-26Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Cartia and aspirin in preeclampsia (2 arms), sponsored by Vall d'Hebron Research Institute. Started Jul 2018; status: completed.
02
Drugs
Cartiaaspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2018-000811-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000811-26.